Immunohistochemistry of non-small cell type of lung cancer can be used as a separate prognostic factor?

被引:0
|
作者
Rahman, Manar A. Abdel [1 ]
Arram, Eman O. [2 ]
Hamid, Amr Abdel [2 ]
机构
[1] Mansoura Univ, Fac Med, Dept Pathol, Mansoura, Egypt
[2] Mansoura Univ, Fac Med, Dept Thorac Med, Mansoura, Egypt
来源
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS | 2019年 / 68卷 / 04期
关键词
immunohistochemistry; lung cancer; prognosis; EXPRESSION; CARCINOMA; BCL-2; KI-67; TTF-1; EGFR; P53;
D O I
10.4103/ejcdt.ejcdt_94_18
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Aim We aim to assess prognostic significance of immunohistochemistry represented in Napsin A and CK 5/6 in NSCLC, Moreover we aim to correlate histologic patterns of adenocarcinoma with Napsin A expression and identify its prognostic significance. Patients and methods The study was conducted on 130 cases diagnosed pathologically as NSCLC, and then we used Napsin A and CK 5/6 for subtyping them into actual histologic types (108 cases were diagnosed as adenocarcinoma and 22 cases as squamous cell carcinoma, we correlated expression levels of Napsin A and CK 5/6 to different clinicopathological variants. Results Napsin A score 2 was high in age more than or equal 60 years while Napsin A score 3 was high in age less than 50 years also Napsin A score 3 was high in cases with lymph node metastasis, while CK 5/6 was associated with cases without distant metastasis. Conclusion Both Napsin A and CK 5/6 could be used as prognostic and diagnostic markers in NSCLC.
引用
收藏
页码:595 / 600
页数:6
相关论文
共 50 条
  • [31] Complement component 3 is a prognostic factor of non-small cell lung cancer
    Lin, Kailong
    He, Siyi
    He, Luhang
    Chen, Junyin
    Cheng, Xiaoming
    Zhang, Guoqiang
    Zhu, Bo
    MOLECULAR MEDICINE REPORTS, 2014, 10 (02) : 811 - 817
  • [32] Serum HE4: An Independent Prognostic Factor in Non-Small Cell Lung Cancer
    Lamy, Pierre-Jean
    Plassot, Carine
    Pujol, Jean-Louis
    PLOS ONE, 2015, 10 (06):
  • [33] Microvessel density as a prognostic factor in non-small cell lung cancer: a meta-analysis
    Zhang, Jing
    Ma, Xuelei
    Li, Yanyan
    Song, Yanlin
    Ma, Guangzhi
    Huang, Jingwen
    Zhu, Chenjing
    Liu, Ming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (09): : 17676 - 17689
  • [34] Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer
    Cathcart, Mary-Clare
    Gately, Kathy
    Cummins, Robert
    Kay, Elaine
    O'Byrne, Kenneth J.
    Pidgeon, Graham P.
    MOLECULAR CANCER, 2011, 10
  • [35] MDMX is a prognostic factor for non-small cell lung cancer and regulates its sensitivity to cisplatin
    Zhao, Han
    Xie, Yu-Zhuo
    Xing, Rui
    Sun, Ming
    Chi, Feng
    Zeng, Yue-Can
    CELLULAR ONCOLOGY, 2017, 40 (04) : 357 - 365
  • [36] Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer
    Cooper, Wendy A.
    Kohonen-Corish, Maija R. J.
    McCaughan, Brian
    Kennedy, Catherine
    Sutherland, Robert L.
    Lee, Cheok Soon
    HISTOPATHOLOGY, 2009, 55 (01) : 28 - 36
  • [37] Restin protein expression in non-small cell lung cancer
    Nana, Frank Aboubakar
    Lamberts, Virginie
    Hoton, Delphine
    Stanciu, Claudia Pop
    Lecocq, Marylene
    Carlier, Francois M.
    Duplaquet, Fabrice
    Pirard, Lionel
    Pilette, Charles
    Bihin, Benoit
    Ocak, Sebahat
    THORACIC CANCER, 2023, 14 (23) : 2302 - 2309
  • [38] CHID1 Is a Novel Prognostic Marker of Non-Small Cell Lung Cancer
    Kovaleva, Olga V.
    Rashidova, Madina A.
    Samoilova, Daria V.
    Podlesnaya, Polina A.
    Tabiev, Rasul M.
    Mochalnikova, Valeria V.
    Gratchev, Alexei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (01) : 1 - 16
  • [39] Prognostic significance of serum chemerin levels in patients with non-small cell lung cancer
    Xu, Chun-Hua
    Yang, Yang
    Wang, Yu-Chao
    Yan, Jun
    Qian, Li-Hua
    ONCOTARGET, 2017, 8 (14) : 22483 - 22489
  • [40] Vimentin Regulates Invasiveness and Is a Poor Prognostic Marker in Non-small Cell Lung Cancer
    Tadokoro, Akira
    Kanaji, Nobuhiro
    Liu, Dage
    Yokomise, Hiroyasu
    Haba, Reiji
    Ishii, Tomoya
    Takagi, Takehiro
    Watanabe, Naoki
    Kita, Nobuyuki
    Kadowaki, Norimitsu
    Bandoh, Shuji
    ANTICANCER RESEARCH, 2016, 36 (04) : 1545 - 1551